Claim OwnershipJAMA Medical News
Subscribed: 959Played: 16,455
Subscribe
© American Medical Association, 2021
Description
Discussions of timely topics in clinical medicine, biomedical research, public health, health policy, and more, featured in the Medical News section of JAMA, the Journal of the American Medical Association.
190 Episodes
Reverse
College Athlete Deaths by Suicide Have Doubled; Why the Bird Flu Outbreak in Dairy Cows Matters; Combined COVID-19 and Flu Vaccines Could Be Available Next Year Related Content: College Athlete Deaths by Suicide Have Doubled, and Researchers Want to Know Why Bird Flu Outbreak in Dairy Cows Is Widespread, Raising Public Health Concerns Combined Vaccines Against COVID-19, Flu, and Other Respiratory Illnesses Could Soon Be Available
Can AI augment radiological processes, imaging analysis, and diagnosis? In this Q&A, Saurabh Jha, MBBS, MRCS, MS, an associate professor of radiology at the University of Pennsylvania, joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss how AI could play a crucial role in improving access to medical imaging in remote, high-altitude, and low-income areas. Related Content: How Artificial Intelligence Will Enhance Imaging Access and Analysis Algorithms at the Gate—Radiology’s AI Adoption Dilemma
Can AI/machine learning-driven digital phenotyping facilitate global personalized medicine? In this Q&A, Vikram Patel, MBBS, PhD, the Paul Farmer Professor and chair of the Department of Global Health and Social Medicine at Harvard Medical School, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss how AI can enhance assessment and treatment solutions across lower-income nations. Related Content: One Day, AI Could Mean Better Mental Health for All
An Explosion of Food Is Medicine Research Could Change Health Care; Blockbuster Obesity Drugs Have Potential New Uses Related Content: Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? Produce Prescriptions Sound Good, but Data to Support Them Are Lacking—That Could Soon Change
1Douglas Drachman, MD, shares late-breaking research from the annual conference of the American College of Cardiology and World Congress of Cardiology in an interview with JAMA Medical News Director Jennifer Abbasi. Dr Drachman—who chaired this year’s conference—is an interventional cardiologist at Massachusetts General Hospital, where he is also director of education in the cardiology division. Related Content: Clinical Highlights From the American College of Cardiology’s 2024 Scientific Session
Momentum Grows for Disaggregated Asian American Health Data; What Clinicians Need to Know About TikTok Related Content: Researchers Are Working to Disaggregate Asian American Health Data—Here’s Why It’s Long Overdue Patients Are Turning to TikTok for Health Information—Here’s What Clinicians Need to Know
Could generative AI assist in extending access to vulnerable populations and begin to bridge the gap in disparities? In this Q&A, Davey Smith, MD, MAS, an infectious disease specialist and virologist at the University of California, San Diego, joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to explore the implications of large language models for improving patient outcomes. Related Content: Will Generative AI Tools Improve Access to Reliable Health Information?
Measles Is Spreading Again in the US; Questions Surround Blood Tests That Claim to Screen for Multiple Cancers; Study Provides Insight Into Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Related Content: Measles Cases Are Spreading in the US—Here’s What to Know Questions Swirl Around Screening for Multiple Cancers With a Single Blood Test NIH Study Provides Long-Awaited Insight Into Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
AI can understand brain signals linked to the sensory and motor processes involved in speech. In this Q&A, Edward Chang, MD, the chair and professor of neurosurgery at UCSF joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss how AI has the potential to facilitate communication and how close AI development is to being able to translate human emotion. Related Content: Digital Avatars and Personalized Voices—How AI Is Helping to Restore Speech to Patients
Can AI enhance the speed and efficiency of interpreting ultrasounds and echocardiograms, thereby minimizing diagnostic errors? In this Q&A, Rima Arnaout, MD, a cardiologist and associate professor of medicine at the University of California-San Francisco, joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the transformative impact of AI on cardiac imaging. Related Content: How Machine Learning Might Help Improve Cardiac Imaging
Rural Maternity Care Is in Crisis—Here’s What Could Help; Type and Severity of Immunodeficiency Affect Speed of SARS-CoV-2 Clearance, Study Finds Related Content: More Than Half of US Rural Hospitals No Longer Offer Birthing Services—Here’s Why When It Comes to SARS-CoV-2 Clearance, People Who Are Immunocompromised Are Not All Alike
Automation bias and shortcuts in clinical AI models have posed significant challenges. In this Q&A, Jenna Wiens, PhD, an associate professor of Computer Science and Engineering at the University of Michigan in Ann Arbor, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss how we can start leveraging human collaboration with AI to provide more effective health care. Related Content: Blind Spots, Shortcuts, and Automation Bias—Researchers Are Aiming to Improve AI Clinical Models
AI in clinical practice needs ethical frameworks to avert future biases. In this Q&A, Marzyeh Ghassemi, PhD, the Herman L. F. von Helmholtz Career Development Professor at MIT in Electrical Engineering and Computer Science (EECS), joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss ethical machine learning and responsible clinical implementation. Related Content: AI Developers Should Understand the Risks of Deploying Their Clinical Tools, MIT Expert Says
What the Latest Research Says About Paxlovid; People Are Using Potentially Dangerous “Trip-Killers” to Counter Psychedelics; Social Media Affects Youth Mental Health—Here’s What Could Help Related Content: Paxlovid Is Effective but Underused—Here’s What the Latest Research Says About Rebound and More Study Finds Hundreds of Reddit Posts on “Trip-Killers” for Psychedelic Drugs Social Media Industry Standards Needed to Protect Adolescent Mental Health, Says National Academies
After a Decade, Goodbye to the Pooled Cohort Equations? Experts Tackle Racial Bias in Clinical Algorithms; How COVID-19 Might Be Tied to Other Respiratory Disease Outbreaks Related Content: What to Know About PREVENT, the AHA’s New Cardiovascular Disease Risk Calculator Citing Harms, Momentum Grows to Remove Race From Clinical Algorithms From “Immunity Debt” to “Immunity Theft”—How COVID-19 Might Be Tied to Recent Respiratory Disease Surges
How can we leverage AI to transform health care into a more efficient model for delivering care? In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews Atul Butte, MD, PhD, the director of the Bakar Computational Health Sciences Institute at UCSF, to discuss scalable privilege and the need for the broad distribution of AI-driven expertise. Related Content: “Scalable Privilege”—How AI Could Turn Data From the Best Medical Systems Into Better Care for All
Amid the surging buzz around artificial intelligence (AI), can we trust the Al hype, and more importantly, are we ready for its implications? In this Q&A, Arvind Narayanan, PhD, a professor of computer science at Princeton, joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the exploration of Al's fairness, transparency, and accountability. Related Content: How to Navigate the Pitfalls of AI Hype in Health Care
The Next Generation of COVID-19 Vaccines May Be Inhaled; Does Paxlovid Prevent Long COVID? Apply to the Morris Fishbein Fellowship in Medical Editing. Related Content: Up the Nose and Down the Windpipe May Be the Path to New and Improved COVID-19 Vaccines Studies Investigate Whether Antivirals Like Paxlovid May Prevent Long COVID The Morris Fishbein Fellowship in Medical Editing
Artificial intelligence holds the promise of revolutionizing disease diagnosis and prediction, but it also presents a pivotal challenge: ensuring equity. In this Q&A, Alondra Nelson, PhD, the Harold F. Linder Professor at the Institute for Advanced Study, joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the equitable regulation of AI to benefit all populations. Related Content: How Do Policymakers Regulate AI and Accommodate Innovation in Research and Medicine?
In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews John Ayers, PhD, MA, vice chief of innovation in the Division of Infectious Diseases & Global Public Health, deputy director of informatics in the Altman Clinical and Translational Research Institute, and affiliate scientist in the Qualcomm Institute, all at UC San Diego, to discuss how genAI programs like ChatGPT can increase communication pathways and improve patient outcomes. Related Content: How AI Assistants Could Help Answer Patients’ Messages—and Potentially Improve Their Outcomes
Comments
Download from Google Play
Download from App Store
United States